TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has provided an update.
Consun Pharmaceutical Group Ltd. has announced a share repurchase program, utilizing a general mandate granted by shareholders. The program aims to repurchase up to HKD200 million worth of shares from the open market, reflecting the company’s confidence in its business prospects and belief that its current share price undervalues its intrinsic worth. This initiative is aligned with the company’s long-term strategy to optimize capital structure and enhance shareholder value, while maintaining sufficient financial resources for ongoing operations.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the development and production of pharmaceutical products. The company is known for its commitment to enhancing its market position and optimizing its capital structure.
Average Trading Volume: 2,298,188
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.54B
See more insights into 1681 stock on TipRanks’ Stock Analysis page.